392
Views
4
CrossRef citations to date
0
Altmetric
INFECTIOUS DISEASE: Original Article

Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant

, , , , &
Pages 1061-1070 | Accepted 23 May 2013, Published online: 17 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rayo Morfín-Otero, Martha Alvarado-Ibarra, Eduardo Rodriguez-Noriega, Jesus Resendiz-Sanchez, Dipen A Patel, Jennifer M Stephens, Manuela Di Fusco, Carlos F Mendoza & Claudie Charbonneau. (2018) Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico. ClinicoEconomics and Outcomes Research 10, pages 511-520.
Read now
David I. Marks, Qifa Liu & Monica Slavin. (2017) Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation. Expert Review of Anti-infective Therapy 15:5, pages 493-502.
Read now

Articles from other publishers (2)

Yuanming Xing, Lu Chen, Yan Feng, Yan Zhou, Yajing Zhai & Jun Lu. (2017) Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections. BMC Infectious Diseases 17:1.
Crossref
Carlos Solano, Monica Slavin, Alissa J. Shaul, David I. Marks, Catherine Cordonnier, Oliver A. Cornely, Antonio Pagliuca, Lael Cragin, Isidro Jarque, Carolina Garcia-Vidal, Sonja Sorensen, David J. Vanness, Claudie Charbonneau, Jon Andoni Barrueta, Carmen Peral, Marina De Salas-Cansado & Eric J. Bow. (2017) Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant. Mycoses 60:2, pages 79-88.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.